- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/08 - Bronchodilators
Patent holdings for IPC class A61P 11/08
Total number of patents in this class: 589
10-year publication summary
|
16
|
17
|
24
|
32
|
50
|
45
|
43
|
29
|
41
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chiesi Farmaceutici S.p.A. | 968 |
29 |
| AstraZeneca AB | 2900 |
23 |
| Verona Pharma plc | 108 |
17 |
| Almirall, S.A. | 491 |
10 |
| Daiichi Sankyo Company, Limited | 1874 |
10 |
| Bayer AG | 3336 |
9 |
| Pulmagen Therapeutics (Synergy) Limited | 20 |
8 |
| Theravance Biopharma R&D IP, LLC | 458 |
8 |
| Glaxo Group Limited | 4065 |
7 |
| Boehringer Ingelheim International GmbH | 4644 |
7 |
| Bayer Pharma AG | 1047 |
7 |
| Vertex Pharmaceuticals Incorporated | 1595 |
7 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 708 |
6 |
| Cipla Limited | 465 |
6 |
| Nippon Shinyaku Co., Ltd. | 324 |
6 |
| Ube Industries, Ltd. | 848 |
6 |
| F. Hoffmann-La Roche AG | 7920 |
5 |
| Norton (Waterford) Limited | 234 |
5 |
| Respiratorius AB | 10 |
5 |
| Reistone Biopharma Company Limited | 24 |
5 |
| Other owners | 403 |